Policy Brief
Consolidated Guidelines
Updated 2016
WHO/HIV/2017.05
Accelerating HIV prevention to reduce new infections by 75%
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 ...(30%) had dolutegravir HIVDR. Malawi urgently requires adequate HIVDR testing capacity.
more
Miscellaneous
Chapter J.2
Lancet Planet Health 2021; 5: e654–58